NIC/ US62914B1008 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
05-14
Northern Wisconsin Jellystone Park Gets Extreme Makeover with More Water Attractions and Glamping Op...
GlobeNewswire
05-14
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire
05-02
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financi...
GlobeNewswire
04-30
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, M...
GlobeNewswire
04-25
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
GlobeNewswire
04-25
OKX Continues to Lead in Trust and Transparency with 18th Consecutive Proof of Reserves, Amounting t...
GlobeNewswire
04-24
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase ...
GlobeNewswire
04-11
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Offi...
GlobeNewswire
04-08
Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Offi...
GlobeNewswire
04-04
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a ...
GlobeNewswire
04-01
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire
03-28
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treat...
GlobeNewswire
03-28
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial ...
GlobeNewswire
03-28
OKX Publishes 17th Consecutive Proof of Reserves, Highlighting USD22.1 Billion in Primary Assets
GlobeNewswire
03-27
Avantax Welcomes Financial Advisors Heidi and Nicholas Irwin, Longtime Fixtures of the Lockhart, Tex...